EUVIMEDEUVIMED entdecken
Crossref

Stratification by Ki-67 Labeling Index Increases Specificity of p16INK4a Expression as a Surrogate Marker for CDKN2A Inactivation in Meningioma

Kevin Y Zhang, Kanish Mirchia, Arie Perry, Charles G Eberhart, David R Raleigh, David A Solomon, Calixto-Hope G Lucas, Vivian Tang

Modern Pathology · 2026

DOI: 10.1016/j.modpat.2026.101024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2026. Verfasst von Kevin Y Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Johns Hopkins University, Baltimore, Maryland. Hauptthemen laut MEDLINE: Meningioma, Ki-67 Antigen, Biomarkers, Tumor, Cyclin-Dependent Kinase Inhibitor p16. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National Cancer Institute, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MeningiomaKi-67 AntigenBiomarkers, TumorCyclin-Dependent Kinase Inhibitor p16Meningeal NeoplasmsHumansFemaleMaleMiddle AgedAgedAdultImmunohistochemistry

Stichwörter der Autor:innen

World Health Organization gradingdigital quantificationmolecular neuropathologyproliferation indexsurrogate markers

Substanzen

Ki-67 AntigenBiomarkers, TumorCyclin-Dependent Kinase Inhibitor p16CDKN2A protein, human

Autor:innen und Institutionen

  • Department of Pathology, Johns Hopkins University, Baltimore, Maryland.
  • Department of Pathology, University of California San Francisco, San Francisco, California.
  • Department of Radiation Oncology, University of California San Francisco, San Francisco, California.
  • Department of Pathology, Stanford University, Palo Alto, California.
  • Department of Pathology, Johns Hopkins University, Baltimore, Maryland. Electronic address: clucas7@jhmi.edu.

Förderung

  • National Cancer Institute
  • National Institutes of Health

Zitieren

APA

Zhang, K. Y., Mirchia, K., Perry, A., Eberhart, C. G., Raleigh, D. R., Solomon, D. A., Lucas, C. G., & Tang, V. (2026). Stratification by Ki-67 Labeling Index Increases Specificity of p16INK4a Expression as a Surrogate Marker for CDKN2A Inactivation in Meningioma. Modern Pathology. https://doi.org/10.1016/j.modpat.2026.101024

Vancouver

Zhang KY, Mirchia K, Perry A, Eberhart CG, Raleigh DR, Solomon DA, et al. Stratification by Ki-67 Labeling Index Increases Specificity of p16INK4a Expression as a Surrogate Marker for CDKN2A Inactivation in Meningioma. Modern Pathology. 2026. doi:10.1016/j.modpat.2026.101024

BibTeX
@article{Zhang2026,
  author = {Zhang, Kevin Y and Mirchia, Kanish and Perry, Arie and Eberhart, Charles G and Raleigh, David R and Solomon, David A and Lucas, Calixto-Hope G and Tang, Vivian},
  title = {Stratification by Ki-67 Labeling Index Increases Specificity of p16INK4a Expression as a Surrogate Marker for CDKN2A Inactivation in Meningioma},
  journal = {Modern Pathology},
  year = {2026},
  doi = {10.1016/j.modpat.2026.101024}
}
Kostenlos starten →